TrialFrontiers in immunology2023

Nebulized glycyrrhizin/enoxolone drug modulates IL-17A in COVID-19 patients: a randomized clinical trial.

Ulises Zendejas-Hernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.